Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant sequential epirubicin, cyclophosphamide, and paclitaxel for women with high-risk early breast cancer (Neo-tAnGo): an open-label, 2×2 factorial randomised phase 3 trial-Reference-Cited by-同舟云学术

Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant sequential epirubicin, cyclophosphamide, and paclitaxel for women with high-risk early breast cancer (Neo-tAnGo): an open-label, 2×2 factorial randomised phase 3 trial

Published:2014-02 Issue:2 Volume:15 Page:201-212
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Earl Helena M,Vallier Anne-Laure,Hiller Louise,Fenwick Nicola,Young Jennie,Iddawela Mahesh,Abraham Jean,Hughes-Davies Luke,Gounaris Ioannis,McAdam Karen,Houston Stephen,Hickish Tamas,Skene Anthony,Chan Stephen,Dean Susan,Ritchie Diana,Laing Robert,Harries Mark,Gallagher Christopher,Wishart Gordon,Dunn Janet,Provenzano Elena,Caldas Carlos

Publisher

Elsevier BV

Subject

Oncology

Reference39 articles.

1. GLOBOCAN 2008 version 1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No 10;Ferlay,2010

2. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials;Lancet,2012

3. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials;Lancet,2005

4. Adjuvant cyclophosphamide, methotrexate, and fluorouracil versus fluorouracil, epirubicin, and cyclophosphamide chemotherapy in premenopausal women with axillary node-positive operable breast cancer: results of a randomized trial;Coombes;J Clin Oncol,1996

5. Randomised trial of intensive cyclophosphamide, epirubicin, and fluorouracil compared with cyclophosphamide, methotrexate and fluorouracil in pre-menopausal women with node-positive breast cancer;Levine;J Clin Oncol,1998

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of inter-cycle treatment delays on 5-year all-cause mortality in early-stage breast cancer: A retrospective cohort study;European Journal of Cancer;2024-10

2. Racial and Ethnic Disparities in European Breast Cancer Clinical Trials;Cancers;2024-04-29

3. Different Chemotherapy Regimens and Pathologic Complete Response in Triple-Negative Breast Cancer: An Updated Network Meta-Analysis of Phase 3 Trials;Medicina;2024-02-19

4. The Impact of Inter-Cycle Treatment Delays on 5-Year All-Cause Mortality in Early-Stage Breast Cancer;2024

5. Novel Strategies Using Sagacious Targeting for Site-Specific Drug Delivery in Breast Cancer Treatment: Clinical Potential and Applications;Critical Reviews™ in Therapeutic Drug Carrier Systems;2024